REDWOOD CITY, Calif.,
Jan. 24, 2012 /PRNewswire/
-- Codexis, Inc. (Nasdaq: CDXS) today announced that the
Company's Chief Financial Officer, Robert
Lawson, has advised the Company of his decision to resign as
Chief Financial Officer in order to accept a position at a private
software company. The Board of Directors will conduct an
immediate search for a new CFO.
"We thank Bob for his contributions to Codexis," said
Alan Shaw, Ph. D, President and
Chief Executive Officer. "We are grateful for his leadership, and
we all wish Bob the best as he returns to the software
industry."
In order to facilitate an orderly transition, Mr. Lawson will
remain with the Company as Chief Financial Officer to oversee the
year-end accounting close and annual audit process, and the filing
of the Company's Annual Report on Form 10-K. Mr. Lawson will
discuss Codexis' fourth quarter and full year 2011 financial
results on its fiscal 2011 earnings conference call on February 7, 2012.
About Codexis
Codexis is an industrial biotechnology company developing
high value sustainable chemicals, clean fuels, cost effective
pharmaceutical processes and renewable bioindustrial
ingredients to make industry more efficient, productive and
profitable. Partners and customers include global leaders
such as Shell, Merck and Pfizer. For more information, see
www.codexis.com.
Contacts:
Media: Wes Bolsen,
wes.bolsen@codexis.com, 650.421.8100
Investors: Jay Sarwar,
ir@codexis.com, 650.421.8126
SOURCE Codexis, Inc.